Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHO’s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs
Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHO’s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs
<iframe src="https://hindustansphere.com/embed/cluster/e71ca861d289b0db54effd21c4ca2abcc62dc73f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Three common medicines classified as carcinogenic by WHO cancer agency"></iframe>
Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHO’s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs
Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHO’s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs
